Some medicines help chemotherapy drugs work better. That’s also true if yourcancer comes back(called a relapse), or if your current treatment doesn’t help you enough or stops working (called “refractory” multiple myeloma). Your doctor may combine chemo with drugs: Corticosteroids (steroids)l...
If you don't have symptoms, your doctor might start you on one of these drugs to keep myeloma from getting worse. Proteasome inhibitors stop the process that eats up extra proteins in cells. Myeloma cells make lots of proteins. When they build up, the cancer cells die. These drugs include...
Chemo drugs for Myeloma Description Uses of Lenalid (Lenalidomide) Capsule Multiple Myeloma Lenalid (Lenalidomide) is the generic name of the Revlimid. It used to treat Multiple Myeloma with the combination of dexamethasone. Myelodysplastic syndrome This medication is also used in the treatment of...
Researchers at Princess Margaret Cancer Centre have discovered why multiple myeloma, an incurable cancer of the bone marrow, seems to return even after an initially effective treatment; the answer is Cancer Stem Cells which lie at the heart of tumours and the fact that the chemotherapy drug Velcad...
Chemo for Smoldering Multiple Myeloma? Not Yet!by definition—so it will take a lot of really good-quality days later to and smoldering multiplemyeloma based on multiparameter flow cytometry analysis of bone marrow plasma dexamethasone as initial therapy for newly diagnosed mu...
High-dose therapy/autologous stem cell transplantation in patients with chemosensitive myeloma: predictors of complete remission Bone Marrow Transplant, 33 (2004), pp. 61-64 CrossrefView in ScopusGoogle Scholar 18. J.J. Lahuerta, M.V. Mateos, J. Martínez-López, et al. Influence of pre- ...
Multiple myeloma (MM) is a cancer of mature plasma cells, which are a type of white blood cell that produces immunoglobulins (antibodies). Antibodies are normally produced to protect the body from microbes, such as bacteria. In multiple myeloma, the monoclonal plasma cells produce a monoclonal ...
Multiple myeloma (MM) is a hematological cancer characterized by the abnormal proliferation of plasma cells. Initial treatments often include immunomodulatory drugs (IMiDs), proteasome inhibitors (PIs), and monoclonal antibodies (mAbs). Despite salient p
Idecabtagene vicleucel in relapsed and refractory multiple myeloma. N Engl J Med. 2021;384(8):705-716. doi:10.1056/NEJMoa2024850 CARVYKTI is the first and only BCMA-targeted treatment approved by the US FDA for patients with relapsed or refractory multiple myeloma who have received at ...
The role of interferon-α in multiple myeloma is still inconclusive despite many years of clinical evaluation. The clinical application of chemosensitising agents that can inhibit P-glycoprotein (P-gp) expression and function, and particularly the development of more potent P-gp modulators such as ...